In today’s recent session, 0.55 million shares of the I-Mab ADR (NASDAQ:IMAB) have been traded, and its beta is 1.38. Most recently the company’s share price was $0.87, and it changed around -$0.03 or -3.00% from the last close, which brings the market valuation of the company to $67.32M. IMAB at last check was trading at a discount to its 52-week high of $2.00, offering almost -129.89% off that amount. The share price’s 52-week low was $0.84, which indicates that the recent value has risen by an impressive 3.45% since then.

I-Mab ADR stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 4 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 0 recommended IMAB as a Hold, whereas 2 deemed it a Buy, and 0 rated it as Underweight. I-Mab ADR is expected to report earnings per share of -0.05 for the current quarter.

I-Mab ADR (NASDAQ:IMAB) trade information

Instantly IMAB has been showing red trend so far today with a performance of -3.00% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.9700 on recent trading dayincreased the stock’s daily price by 10.31%. The company’s shares are currently up 2.82% year-to-date, but still down -7.99% over the last five days. On the other hand, I-Mab ADR (NASDAQ:IMAB) is -8.11% down in the 30-day period.

I-Mab ADR (IMAB) estimates and forecasts

The year-over-year growth rate is expected to be -100.00%, down from the previous year. Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -18.89%. I-Mab ADR earnings are expected to increase by 82.84% in 2025, but the outlook is positive 33.28% per year for the next five years.

I-Mab ADR (NASDAQ:IMAB)’s Major holders

CALIGAN PARTNERS LP, with 3.8067% or 3.37 million shares worth $5.64 million as of 2024-06-30, holds the second largest percentage of outstanding shares.

abrdn Healthcare Investors and abrdn Healthcare Opportunities Fund were the top two Mutual Funds as of Sep 30, 2024. The former held 53.88 shares worth $47122.0, making up 0.07% of all outstanding shares. On the other hand, abrdn Healthcare Opportunities Fund held roughly 43.74 shares worth around $38248.0, which represents about 0.05% of the total shares outstanding.